EUVIMEDEUVIMED entdecken
Crossref

Targeted delivery of therapeutic oligonucleotides in pancreatic cancer

Yang Iris

Journal of Biology and Medicine · 2022

DOI: 10.17352/jbm.000028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biology and Medicine, 2022. Verfasst von Yang Iris. Die Arbeit nennt 26 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, the most common treatment options for pancreatic cancer include chemotherapy, radiation, and surgery. These treatment options are not specific to the cause of the disease and therefore result in a large number of side effects including nausea, fatigue, hair loss, etc. The use of oligonucleotides may be a more efficient and safe method of cancer therapy. This mini-review will cover how oligonucleotides have been used to treat diseases in the past as well as different methods for delivery into the body and finally the applications of oligonucleotides in pancreatic cancer therapy.

Zitieren

APA

Iris, Y. (2022). Targeted delivery of therapeutic oligonucleotides in pancreatic cancer. Journal of Biology and Medicine. https://doi.org/10.17352/jbm.000028

Vancouver

Iris Y. Targeted delivery of therapeutic oligonucleotides in pancreatic cancer. Journal of Biology and Medicine. 2022. doi:10.17352/jbm.000028

BibTeX
@article{Iris2022,
  author = {Iris, Yang},
  title = {Targeted delivery of therapeutic oligonucleotides in pancreatic cancer},
  journal = {Journal of Biology and Medicine},
  year = {2022},
  doi = {10.17352/jbm.000028}
}
Kostenlos starten →